Literature DB >> 26198026

Clinical Profile of Athletes With Hypertrophic Cardiomyopathy.

Nabeel Sheikh1, Michael Papadakis1, Frédéric Schnell1, Vasileios Panoulas1, Aneil Malhotra1, Mathew Wilson1, François Carré1, Sanjay Sharma2.   

Abstract

BACKGROUND: The phenotype of individuals with hypertrophic cardiomyopathy (HCM) who exercise regularly is unknown. This study characterized the clinical profile of young athletes with HCM. METHODS AND
RESULTS: The electrical, structural, and functional cardiac parameters from 106 young (14-35 years) athletes with HCM were compared with 101 sedentary HCM patients. A subset of athletes with HCM exhibiting morphologically mild (13-16 mm), concentric disease was compared with 55 healthy athletes with mild physiological left ventricular hypertrophy (LVH). Most athletes with HCM (96%) exhibited T-wave inversion and had milder LVH (15.8±3.4 mm versus 19.7±6.5 mm, P<0.001), larger left ventricular cavity dimensions (47.8±6.0 mm versus 44.3±7.7 mm, P<0.001), and superior indices of diastolic function (average E/E' 7.9±2.4 versus 10.7±3.9, P<0.001) compared with sedentary HCM patients. In athletes with HCM, LVH was frequently (36%) confined to the apex and only 15 individuals (14%) exhibited mild concentric LVH mimicking physiological LVH. In these 15 athletes, conventional structural and functional cardiac parameters showed modest sensitivity and specificity for differentiating HCM from physiological LVH: 13% had a left ventricular cavity >54 mm, 87% had a left atrium ≤40, and 100% had an E/E' <12.
CONCLUSIONS: Athletes with HCM exhibit less LVH, larger left ventricular cavities, and normal indices of diastolic function compared with sedentary patients. Only a minority of athletes with HCM constitute the conventional gray zone of mild, concentric LVH. In this minority, conventional echocardiographic parameters alone are insufficient to differentiate HCM from physiological LVH and should be complemented by additional structural and functional assessments to minimize the risk of false reassurance.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  echocardiography; exercise physiology; hypertrophic cardiomyopathy; left ventricular hypertrophy; primary prevention

Mesh:

Year:  2015        PMID: 26198026     DOI: 10.1161/CIRCIMAGING.114.003454

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  21 in total

1.  The Brazilian Society of Cardiology and Brazilian Society of Exercise and Sports Medicine Updated Guidelines for Sports and Exercise Cardiology - 2019.

Authors:  Nabil Ghorayeb; Ricardo Stein; Daniel Jogaib Daher; Anderson Donelli da Silveira; Luiz Eduardo Fonteles Ritt; Daniel Fernando Pellegrino Dos Santos; Ana Paula Rennó Sierra; Artur Haddad Herdy; Claúdio Gil Soares de Araújo; Cléa Simone Sabino de Souza Colombo; Daniel Arkader Kopiler; Filipe Ferrari Ribeiro de Lacerda; José Kawazoe Lazzoli; Luciana Diniz Nagem Janot de Matos; Marcelo Bichels Leitão; Ricardo Contesini Francisco; Rodrigo Otávio Bougleux Alô; Sérgio Timerman; Tales de Carvalho; Thiago Ghorayeb Garcia
Journal:  Arq Bras Cardiol       Date:  2019-03       Impact factor: 2.000

Review 2.  The Impact of Ethnicity on Cardiac Adaptation.

Authors:  Uchenna Ozo; Sanjay Sharma
Journal:  Eur Cardiol       Date:  2020-08-24

Review 3.  Hypertrophic Cardiomyopathy in Athletes.

Authors:  Aneil Malhotra; Sanjay Sharma
Journal:  Eur Cardiol       Date:  2017-12

Review 4.  Cardiac Imaging in the Athlete: Shrinking the "Gray Zone".

Authors:  Mario R Caruso; Lohit Garg; Matthew W Martinez
Journal:  Curr Treat Options Cardiovasc Med       Date:  2020-02-03

Review 5.  Grey zones in cardiomyopathies: defining boundaries between genetic and iatrogenic disease.

Authors:  Giovanni Quarta; Michael Papadakis; Paolo Di Donna; Niccolò Maurizi; Attilio Iacovoni; Antonello Gavazzi; Michele Senni; Iacopo Olivotto
Journal:  Nat Rev Cardiol       Date:  2016-11-10       Impact factor: 32.419

6.  Hypertrophic cardiomyopathy and exercise restrictions: time to let the shackles off?

Authors:  Yuen W Liao; James Redfern; John D Somauroo; Robert M Cooper
Journal:  Br J Cardiol       Date:  2020-05-20

Review 7.  Left Ventricular Hypertrophy in Athletes: Differentiating Physiology From Pathology.

Authors:  Daniel X Augustine; Liz Howard
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-10-26

Review 8.  Recent Advances in Understanding and Managing Cardiomyopathy.

Authors:  Paulino Alvarez; Wh Wilson Tang
Journal:  F1000Res       Date:  2017-09-07

9.  Apical Hypertrophic Cardiomyopathy: The Variant Less Known.

Authors:  Rebecca K Hughes; Kristopher D Knott; James Malcolmson; João B Augusto; Saidi A Mohiddin; Peter Kellman; James C Moon; Gabriella Captur
Journal:  J Am Heart Assoc       Date:  2020-02-28       Impact factor: 5.501

Review 10.  Hypertrophic Cardiomyopathy: Updates Through the Lens of Sports Cardiology.

Authors:  Bradley S Lander; Dermot M Phelan; Matthew W Martinez; Elizabeth H Dineen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.